These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1246040)

  • 21. Influence of clofibrate (ethyl-4-chlorophenoxyisobutyrate) on hepatic drug metabolism in male rats.
    Lewis NJ; Witiak DT; Feller DR
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):281-5. PubMed ID: 4812862
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heredity of hexobarbital sleeping time and efficiency of drug metabolism in Wistar and Sprague-Dawley rats.
    Gut I; Becker BA
    Arch Toxicol; 1975 Sep; 34(1):61-70. PubMed ID: 1242637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the oxidative metabolism of drugs by liver microsomes.
    Kato R; Takayanagi M; Oshima T
    Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the metabolism of drugs by subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Mar; 155(3):479-93. PubMed ID: 6022622
    [No Abstract]   [Full Text] [Related]  

  • 26. Inductive effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane(DDT), phenobarbital, and benzpyrene on microsomal cytochrome B450, ethyl isocyanide spectra, and metabolism in vivo of zoxazolamine and hexobarbital in the mouse.
    Abernathy CO; Philpot RM; Guthrie FE; Hodgson E
    Biochem Pharmacol; 1971 Sep; 20(9):2395-400. PubMed ID: 5163150
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of manganese on the hepatic microsomal mixed function oxidase enzyme system in the rat.
    Deimling MJ; Schnell RC
    Fundam Appl Toxicol; 1984 Dec; 4(6):1009-18. PubMed ID: 6519370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nature of the reverse type I (modified type II) spectral change in liver microsomes.
    Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R
    Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR
    Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.
    Kato R; Onoda K; Sasajima M
    Jpn J Pharmacol; 1970 Jun; 20(2):194-209. PubMed ID: 4393947
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of pregnancy on hepatic microsomal drug metabolism in rabbits and rats.
    Gut I; Becker BA; Gutová M
    Arch Toxicol; 1976 Jan; 35(1):41-7. PubMed ID: 946406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-dependent interaction of microsomal cytochrome P-450 with substrates. I. Effect of pH upon the interaction of exogenous substrates with membrane-bound cytochrome P-450.
    Hachino Y; Matsubara T; Hagihara B
    Chem Biol Interact; 1981 Oct; 37(1-2):181-90. PubMed ID: 7285242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of thiamin antagonists on drug hydroxylation and properties of cytochrome P-450 in the rat.
    Wade AE; Wu BC; Holbrook CM; Caster WO
    Biochem Pharmacol; 1973 Jul; 22(13):1573-80. PubMed ID: 4729804
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of in vivo administration of dimethyl sulfoxide on the in vitro metabolism of some monocyclic aromatic chemicals by hepatic microsomal preparations.
    Stock BH; Fouts JR
    Toxicol Appl Pharmacol; 1971 Apr; 18(4):859-68. PubMed ID: 5570238
    [No Abstract]   [Full Text] [Related]  

  • 37. Growth hormone modulation of liver drug metabolic enzyme activity in the rat. I. Effect of the hormone on the content and rate of reduction of microsomal cytochrome P-450.
    Wilson JT
    Biochem Pharmacol; 1973 Jul; 22(14):1717-28. PubMed ID: 4146051
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of repeated exposure to aniline, nitrobenzene, and benzene on liver microsomal metabolism in the rat.
    Wiśniewska-Knypl JM; Jablońska JK; Piotrowski JK
    Br J Ind Med; 1975 Feb; 32(1):42-8. PubMed ID: 1125127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of puromycin on binding and on metabolism in vitro of substrates by rat liver microsomes.
    Soliman MR; Wade AE
    Biochem Pharmacol; 1972 Oct; 21(19):2652-6. PubMed ID: 4661623
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of magnesium and some other divalent cations on hepatic microsomal drug metabolism in vitro.
    Peters MA; Fouts JR
    Biochem Pharmacol; 1970 Feb; 19(2):533-44. PubMed ID: 4396251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.